Regentis Biomaterials
RGNT----
Regentis Biomaterials (RGNT)
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platf...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Regentis Biomaterials Analyst Rating
View MoreForecast & Rating
Mar 2, 2026Price forecast
$10.00410.20%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 20 at 08:02 AM
Regentis wins Japanese patent allowance for GelrinC solvent-free manufacturing process
- Price Alert · Jul 20 at 08:01 AM
Pre-market hot trades in US stocks: Regentis Biomaterials pre-market up 7.14%, active funds but no positive news
- PUBT · Jul 15 at 08:00 AM
Regentis wins EU approval for new GelrinC manufacturing process
- benzinga_article · Jul 14 at 12:05 PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Tip Ranks · Jul 9 at 03:58 PM
Regentis Biomaterials Shareholders Approve All Proposals at July 9 Adjourned AGM
- PUBT · Jul 9 at 03:33 PM
Regentis Biomaterials holds annual shareholder meeting
